Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 18 | 20 | +2 |
| Shares | 1.99M | 1.27M | −721.6K (−36.2%) |
| Value | $7.33M | $2.96M | −$4.37M (−59.6%) |
New holders (8)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 54,670 | $127.0K | 0.00% |
| Jane Street Group, LLC | 39,680 | $92.0K | 0.00% |
| Commonwealth Equity Services, LLC | 20,200 | $47.0K | 0.00% |
| Citadel Advisors LLC | 14,734 | $34.0K | 0.00% |
| Virtu Financial LLC | 12,200 | $28.0K | 0.00% |
| Advisor Group Holdings, Inc. | 9,000 | $21.0K | 0.00% |
| Cutler Group LP | 700 | $1.00K | 0.00% |
| Focused Wealth Management, Inc | 100 | $0 | 0.00% |
Sold out (6)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Armistice Capital, LLC | 1,068,444 | $3.93M |
| AIGH Capital Management LLC | 150,591 | $554.0K |
| Millennium Management LLC | 74,559 | $274.0K |
| Minot Wealth Management LLC | 25,000 | $92.0K |
| FMR LLC | 600 | $2.00K |
| TCI Wealth Advisors, Inc. | 100 | $0 |